Author

Ayesha Ahmed

The University of Texas Southwestern Medical CenterPrimary ORCID profile (0009-0007-8895-8203 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Ayesha AhmediD1 paper · University Hospital of Wales

Biology Disciplines

Click to filter author papers

Evolutionary Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:proteomics· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Organism:E. coli· 1 Approach:experimental assay· 1 Research Focus:protein folding & dynamics· 1 Approach:statistical model· 1

Frequent Co-Authors

Erdal ToprakiD· 1 shared Ilona Kamila GaszekiD· 1 shared Levent SariiD· 1 shared Manuel Razo‐MejiaiD· 1 shared Milo M. LiniD· 1 shared Muhammed Sadik YildiziD· 1 shared Scott H. SaundersiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

7 top collaborators · 11 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperEvolutionary Biology

Erdal ToprakORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Saturation mutagenesis map of generalist versus specialist adaptations of β-lactamase to novel antibiotics

Ilona Kamila Gaszek, Muhammed Sadik Yildiz, Levent Sari, Ayesha Ahmed, Erdal Toprak, Milo M. Lin

This study maps how β-lactamase mutations confer resistance to different antibiotics, identifying generalist and specialist mutations with distinct mechanisms and positions.

bioRxiv · Oct 14, 2025 · PreprintEvolutionary Biology

Unannotated translation products are widespread in model E. coli

Scott H. Saunders, Ayesha Ahmed, Manuel Razo‐Mejia

The paper identifies hundreds of unannotated translation products in E. coli using a high-throughput reverse genetic approach, including novel polypeptides and chimeric proteins.

bioRxiv · Sep 25, 2025 · PreprintMicrobiology